Jean-Michel Vignaud
Overview
Explore the profile of Jean-Michel Vignaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hergalant S, Casse J, Oussalah A, Houlgatte R, Helle D, Rech F, et al.
Front Oncol
. 2023 Aug;
13:1158773.
PMID: 37601663
Introduction: Meningiomas are the most common type of primary central nervous system tumors. In about 80% cases, these tumors are benign and grow very slowly, but the remainder 20% can...
2.
Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, et al.
Nat Genet
. 2023 Mar;
55(4):607-618.
PMID: 36928603
Malignant pleural mesothelioma (MPM) is an aggressive cancer with rising incidence and challenging clinical management. Through a large series of whole-genome sequencing data, integrated with transcriptomic and epigenomic data using...
3.
Guisier F, Deslee G, Birembaut P, Escarguel B, Chapel F, Bota S, et al.
Eur Respir J
. 2022 Mar;
60(3).
PMID: 35236723
Background: 3-9% of low-grade preinvasive bronchial lesions progress to cancer. This study assessed the usefulness of an intensive bronchoscopy surveillance strategy in patients with bronchial lesions up to moderate squamous...
4.
Salle F, Le Stang N, Tirode F, Courtiol P, Nicholson A, Tsao M, et al.
J Thorac Oncol
. 2020 Mar;
15(6):1037-1053.
PMID: 32165206
Introduction: Histologic subtypes of malignant pleural mesothelioma are a major prognostic indicator and decision denominator for all therapeutic strategies. In an ambiguous case, a rare transitional mesothelioma (TM) pattern may...
5.
Treffel M, Lardenois E, Larousserie F, Karanian M, Gomez-Brouchet A, Bouvier C, et al.
Am J Surg Pathol
. 2019 Oct;
44(1):1-10.
PMID: 31651524
Denosumab, an antibody directed against receptor activator of nuclear factor-κB ligand (RANKL), has recently been introduced in the treatment strategy of giant cell tumor of bone. In this study, we...
6.
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions
Alcala N, Mangiante L, Le-Stang N, Gustafson C, Boyault S, Damiola F, et al.
EBioMedicine
. 2019 Oct;
48:191-202.
PMID: 31648983
Background: Malignant Pleural Mesothelioma (MPM) is an aggressive disease related to asbestos exposure, with no effective therapeutic options. Methods: We undertook unsupervised analyses of RNA-sequencing data of 284 MPMs, with...
7.
Mansuet-Lupo A, Filaire M, Chaffanjon P, Alifano M, Forest F, Gibault L, et al.
Ann Pathol
. 2019 Oct;
39(6):425-432.
PMID: 31604575
Gross examination is an essential step for pathological report of a surgical sample. It includes the description of the surgical specimen and their disease(s), the precise and exhaustive sampling of...
8.
Dacic S, Le Stang N, Husain A, Weynand B, Beasley M, Butnor K, et al.
Mod Pathol
. 2019 Jul;
33(2):255-262.
PMID: 31273316
The percentage of sarcomatoid component has an impact on prognosis in patients with biphasic malignant pleural mesothelioma. Recent study showed that the transitional pattern similar to sarcomatoid component of malignant...
9.
Pierre C, Agopiantz M, Brunaud L, Battaglia-Hsu S, Max A, Pouget C, et al.
Virchows Arch
. 2019 Mar;
474(6):721-734.
PMID: 30868297
Current histoprognostic parameters and prognostic scores used in paragangliomas and pheochromocytomas do not adequately predict the risk of metastastic progression and survival. Here, using a series of 147 cases of...
10.
Yguel C, Clauzon D, Lacomme S, Lomazzi S, Lardenois E, Pouget C, et al.
Ann Pathol
. 2019 Mar;
39(6):414-424.
PMID: 30853495
Introduction: PELICAN ("Partager Efficacement en Laboratoire les Informations des Comptes rendus ANatomopathologiques") is a software, which generates standardized reports, and allows to automatically create a database. It has been used...